O-GlcNAcylation Regulation of SNAP29-Dependent Autophagy Activation Dictates Chemoresistance in Gastric Cancer

Liang Tang1, Shaoji Zhao1, Ziling Shao1

  • 1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.

Insights

Low O-GlcNAc transferase (OGT) and O-linked β-N-acetylglucosamine modification (O-GlcNAcylation) levels paradoxically promote chemoresistance in gastric cancer (GC). Enhancing O-GlcNAcylation sensitizes GC to chemotherapy, identifying OGT as a therapeutic target.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Chemoresistance to fluoropyrimidine and platinum agents is a major challenge in gastric cancer (GC).
  • The role of O-GlcNAc transferase (OGT) and O-GlcNAcylation in GC chemoresistance is not well understood.
  • OGT is often elevated in cancers, but its function in GC chemotherapy response is unclear.

Purpose of the Study:

  • To investigate the role of OGT and O-GlcNAcylation in GC chemoresistance.
  • To elucidate the molecular mechanisms underlying OGT's function in GC chemotherapy response.
  • To evaluate OGT as a potential therapeutic target for overcoming GC chemoresistance.

Main Methods:

  • Analysis of OGT expression and patient prognosis in GC.
  • In vitro and in vivo experiments involving OGT knockdown and O-GlcNAcylation inhibition.
  • Mechanistic studies using protein interaction assays, mass spectrometry, and molecular dynamics simulations.
  • Assessment of autophagy pathway modulation and response to chemotherapy agents (5-FU, OXA).
  • Evaluation of Thiamet-G as an O-GlcNAcylation enhancer in vivo.

Main Results:

  • Low OGT/O-GlcNAcylation levels correlate with resistance to 5-FU or oxaliplatin (OXA) in GC.
  • High OGT expression is associated with better prognosis in GC patients receiving fluoropyrimidine/platinum chemotherapy.
  • OGT inhibition or knockdown enhances chemoresistance, while OGT upregulation or O-GlcNAcylation enhancement sensitizes tumors to chemotherapy.
  • OGT O-GlcNAcylates SNAP29, inhibiting STX17-SNAP29-VAMP8 complex formation and autophagosome maturation.
  • Loss of SNAP29 O-GlcNAcylation promotes autophagy and chemoresistance.
  • Chemotherapy treatment downregulates OGT and O-GlcNAcylation, potentially creating a resistance loop.
  • Thiamet-G treatment sensitizes GC tumors to chemotherapy in vivo.

Conclusions:

  • The OGT/SNAP29 axis plays a context-dependent role in regulating GC chemoresistance through autophagy.
  • Low OGT/O-GlcNAcylation promotes chemoresistance by enhancing protective autophagy.
  • Targeting OGT or enhancing O-GlcNAcylation represents a promising strategy to overcome chemoresistance in gastric cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...